ArticleBioscience reports2021

MiR-27a-3p enhances the cisplatin sensitivity in hepatocellular carcinoma cells through inhibiting PI3K/Akt pathway.

Ying Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.